Kidney Biopsy
OtherPatients scheduled to undergo a clinically indicated kidney biopsy will be requested to consent to an additional renal core and various patient-derived samples.
NCT Number: NCT03929887
Glomerulonephritis (GN) generates an enormous individual and social economic burden. However, the therapeutic options are largely based on clinical and pathological parameters and the individual response to therapy or prognosis is uncertain.
Recently, along with advances in molecular analysis and computational bioinformatics, genomic data from human renal biopsies could provide a strong foundation for the future of precision medicine in nephrology.
In response to a request for applications by the Ministry of Health and Welfare of Korea for the creation of Clinical Research Registry, multi-center N network has been established for prospective cohort with kidney biopsy samples (KORNERSTONE).
Through this Network the investigators hope to understand the fundamental biology of glomerulonephritis and aim to bank long-term observational data and corresponding biological data including genomic data from kidney tissues, and kidney pathologic data which is digitalized This database is archived to a web-based platform to access easily and further enrich for researchers.
Interested in participating?
Request InfoAll sexes
Observational
KangWon National University Hospital, Chuncheon, South Korea
Glomerulonephritis (GN) such as Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), Membranous nephropathy (MN), and Immunoglobulin A nephropathy (IgAN) has quite a common clinical presentation often results in renal insufficiency which generates an enormous individual and social economic burden.
However, the therapeutic options are largely based on clinical and pathological parameters and the individual response to therapy or prognosis is uncertain.
Recently, along with advances in molecular analysis and computational bioinformatics, genomic data from human renal biopsies could provide a strong foundation for the future of precision medicine in nephrology.
In response to a request for applications by the Ministry of Health and Welfare of Korea for the creation of Clinical Research Registry, a number of universities joined together to establish Korean Kidney Biopsy Network (KORNERSTONE).
Through this Network the investigators hope to understand the fundamental biology of glomerulonephritis and aim to bank long-term observational data and corresponding biological data including genomic data from kidney tissues, and kidney pathologic data which is digitalized This database is archived to a web-based platform to access easily and further enrich for researchers.
============ <Patient clinical data will be collected as follows>
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Patients scheduled to undergo a clinically indicated kidney biopsy will be requested to consent to an additional renal core and various patient-derived samples.
Time frame: 60 months
Documentation of death from any cause
Time frame: 60 months
Time frame: 60 months
Remission of glomerulonephritis and proteinuria <0.3g/day (pateint who have proteinuria<0.3g/day at baseline have no improvement in clinical outcomes)
Time frame: 60 months
Any cancer diagnosis of the skin, hematopoietic system, or solid organ after enrollment
Time frame: 60 months
Documented infection of any vital organ requiring the use of parenteral and/or oral antibiotics.
Time frame: 60 months
Documented diagnosis of acute kidney injury as defined by the RIFLE criteria and/or renal failure requiring renal replacement therapy <3 months.
Time frame: 60 months
Documented hospital admission, including observation for ≥24 hours.
Time frame: 60 months
Documented visit to an emergency department or observation unit that does not lead to hospitalization and is less than 24 hours.
Time frame: 60 months
Myocardial infarction; Congestive heart failure; Primary intractable serious arrhythmia; Peripheral vascular disease; Ischemic cerebrovascular accident; Hemorrhagic cerebrovascular accident; Thromboembolic event
Time frame: 60 months
Diagnosis of diabetes as indicated by 1 or more of the following not present at enrollment
Contact information is provided by the study sponsor or research team.
Eunyoung Kim
CONTACT
Yong Chul Kim, MD,PhD.
CONTACT
Seoul National University Hospital
Other
Multicenter Prospective Cohort of Kidney Biopsy for Glomerular Disease Research
Acronym: KORNERSTONE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05505500
Autoimmune Diseases, Disease
Ann Arbor, Michigan, United States
View Trial DetailsNCT01835639
Autoimmune Diseases, Female Urogenital Diseases
Wilmington, Delaware, United States
View Trial DetailsNCT00255398
Collapsing Glomerulopathy, Diabetes Complications
Bethesda, Maryland, United States
View Trial DetailsNCT00977977
Autoimmune Disease, Autoimmune Diseases
Bethesda, Maryland, United States
View Trial Details